| ISIN | CH0105325903 |
|---|---|
| Valor Number | 10532590 |
| Bloomberg Global ID | BBG000Q4D8L7 |
| Fund Name | Tavau Swiss Fund CHF |
| Fund Provider |
LLB Swiss Investment AG
Zürich, Switzerland Phone: +41 58 523 96 70 Web: www.llbswiss.ch |
| Fund Provider | LLB Swiss Investment AG |
| Representative in Switzerland | |
| Distributor(s) |
Bank J. Safra Sarasin & Cie AG Basel Phone: +41 61 277 77 77 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 311.11 CHF | 20.11.2025 |
|---|---|---|
| Previous Price * | 309.83 CHF | 19.11.2025 |
| 52 Week High * | 314.68 CHF | 31.10.2025 |
| 52 Week Low * | 257.29 CHF | 09.04.2025 |
| NAV * | 311.11 CHF | 20.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 281,185,479 | |
| Unit/Share Assets *** | 276,876,421 | |
| Trading Information SIX | ||
| YTD Performance | +13.91% |
30.12.2024 - 20.11.2025
30.12.2024 20.11.2025 |
|---|---|---|
| 1 month | +0.47% |
20.10.2025 - 20.11.2025
20.10.2025 20.11.2025 |
| 3 months | -0.09% |
20.08.2025 - 20.11.2025
20.08.2025 20.11.2025 |
| 6 months | +5.95% |
20.05.2025 - 20.11.2025
20.05.2025 20.11.2025 |
| 1 year | +14.48% |
20.11.2024 - 20.11.2025
20.11.2024 20.11.2025 |
| 2 years | +27.82% |
20.11.2023 - 20.11.2025
20.11.2023 20.11.2025 |
| 3 years | +36.52% |
21.11.2022 - 20.11.2025
21.11.2022 20.11.2025 |
| 5 years | +41.63% |
20.11.2020 - 20.11.2025
20.11.2020 20.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG Dividend Right Cert. | 6.98% | |
|---|---|---|
| Novartis AG | 5.57% | |
| Sika AG 0.15% | 4.73% | |
| HBM Healthcare Investments AG Ord | 4.50% | |
| LafargeHolcim Ltd | 4.34% | |
| ABB Ltd | 4.13% | |
| Swiss Re AG | 3.85% | |
| Zurich Insurance Group AG | 3.61% | |
| Cantex Mine Development Corp | 3.49% | |
| SoftwareONE Holding AG Ordinary Shares | 3.13% | |
| Last data update | 31.12.2019 | |
| TER | 2.61% |
|---|---|
| TER date | 31.12.2024 |
| Performance Fee *** | 15.00% |
| PTR | 87.00% |
| Max. Management Fee *** | 1.70% |
| Ongoing Charges *** | 2.61% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |